Hero image

COVID-19

We’ve been committed to developing an effective response to the COVID-19 pandemic since it was first recognised. As a company with a long legacy of research in infectious disease, it is our responsibility to mobilise our scientific expertise and experience to help address the pandemic.

Our research efforts

In collaboration with Ridgeback Biotherapeutics, we have been advancing our research and development efforts for our antiviral COVID-19 medicine.

We are working with regulatory authorities around the world to make our antiviral treatment available globally. We are also continuing our research and development efforts to investigate broader uses of our antiviral medicine.

Clinical trials

Our clinical development program includes several preclinical and early-phase studies, and two Phase 3 trials.

Everything we do must be through the lens of patients and their carers

Michael Azrak shares his views on why it's more important than ever for the voice of patients to be recognised and heard across the Australian healthcare system.

Read more

Next: Everything we do must be through the lens of patients and their carers

Harnessing tech to eliminate distance in a virtual world

An award-winning program has been key to our continued success despite limitations imposed by the COVID-19 pandemic

Read more

Next: Harnessing tech to eliminate distance in a virtual world

Everything we do must be through the lens of patients and their carers

Michael Azrak shares his views on why it's more important than ever for the voice of patients to be recognised and heard across the Australian healthcare system.

Read more

Next: Everything we do must be through the lens of patients and their carers

Harnessing tech to eliminate distance in a virtual world

An award-winning program has been key to our continued success despite limitations imposed by the COVID-19 pandemic

Read more

Next: Harnessing tech to eliminate distance in a virtual world

Previous
Next